Endava (NYSE:DAVA – Free Report) had its target price decreased by Wedbush from $65.00 to $50.00 in a report released on Thursday morning, Benzinga reports. Wedbush currently has an outperform rating on the stock. A number of other analysts also recently issued reports on the stock. Morgan Stanley reiterated an equal weight rating and issued […]